Second Half Financial Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$665K Buy
11,545
+1,744
+18% +$100K 0.27% 49
2026
Q1
$594K Buy
+9,801
New +$571K 0.27% 45
2022
Q3
Sell
-61,013
Closed -$3.85M 40
2022
Q2
$3.85M Hold
61,013
2.96% 15
2022
Q1
$3.85M Buy
+61,013
New +$4.1M 2.96% 15

Other funds holding BMY

Second Half Financial Partners's BMY Position: Q2 2026 in Review

Second Half Financial Partners increased its Bristol-Myers Squibb (BMY) stake by 18% in Q2 2026, buying an estimated $100K and bringing the position to 11,545 shares worth $665K. The position accounts for 0.27% of the portfolio, ranked #49.

Second Half Financial Partners first reported a position in BMY in Q1 2022 and has held it in 4 quarters since. The position peaked at $3.85M in Q2 2022. 440 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Second Half Financial Partners held 11,545 shares of Bristol-Myers Squibb worth $665K as of Q2 2026.
  • Second Half Financial Partners bought 1,744 Bristol-Myers Squibb shares in Q2 2026, an estimated $100K.
  • Bristol-Myers Squibb made up 0.27% of Second Half Financial Partners's portfolio in Q2 2026, its #49 holding.
  • Second Half Financial Partners first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 4 quarters since.
  • Second Half Financial Partners's Bristol-Myers Squibb position peaked at $3.85M in Q2 2022.
  • 440 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Second Half Financial Partners's 13F filing for Q2 2026, filed 17 Jul 2026.